Mr. KT Rama Rao, Minister for Industries & Commerce, Government of Telangana inaugurated the 1st Phase of Sahajanand Medical Technologies (SMT) ‘Global Hub for Manufacturing and R&D’ of minimally invasive cardiovascular devices at the Medical Devices Park in Hyderabad.
Sri Dhirajlal Kotadia, Chairman, Sahajanand Group of Companies, Mr K Prabhakar Reddy, Member of Parliament, Medak, Mr. G Mahipal Reddy, Member of Legislative Assembly (MLA), Patancheru, Mr. G Ballamallu, Chairman, TSIIC, Mr. Jayesh Ranjan, IAS, Principal Secretary, (IT, E&C), Govt. of Telangana, Mr. EV Narsimha Reddy, VC & MD, TSIIC, Mr. Shakthi Nagappan, Director (LS), Government of Telangana, Mr. Bhargav Kotadia, Managing Director, SMT, Mr. Ganesh Sabat, Chief Executive Officer, SMT, leaders of various medtech companies, senior clinicians, cardiologists and healthcare leaders were present.
SMT is a global leader and amongst the largest cardiovascular manufacturing companies in structural and interventional devices. This will be the second manufacturing unit of SMT that will manufacture 1.2 million stents and 2 million catheters when in full capacity. The facility will also boast minimally invasive new-age and highly advanced cardiac products like Transcatheter Aortic Valve Implantation (TAVI) and Heart Occluders used in patients ranging from the elderly population to paediatrics.
This state-of-the-art manufacturing campus will also house SMT’s R&D centre, which will be focused towards developing advanced medical products in interventional, structural, endovascular and closure products in the niche domain of cardiology. The manufacturing unit will be instrumental in generating employment opportunities for close to 2000 people in the state. In addition to this, the global R&D centre will employ over 300 highly qualified scientists. The facility will give a significant boost to ‘Make in India’ stent manufacturing and reducing India’s dependency on foreign stents which are imported with heavy duties.
Mr KTR while congratulating SMT on the inauguration of the first Phase said “Over the years the State of Telangana has recognised the medical device segment as a high-potential, high growth sector, which presents unlimited opportunities and a preferred destination for investment and expansion. We have made sure that we have a skilled workforce, favourable policies, and best-in-class infrastructure to help companies set up facilities that are of global standards. Today’s inauguration of SMT’s state-of-the-art stent manufacturing and cardiac devices facility is a step towards making available high quality, indigenously made, affordable healthcare products that will be made from the state of Telangana for a global populace. I am also happy to learn that this facility when fully operational, will create direct employment of over 2,000 people, besides indirect employment throughout the value chain.”
By Gollapudi Srinivasa Rao